Association of VEGF-1499C→T polymorphism with diabetic nephropathy in type 1 diabetes mellitus

Journal of Diabetes and its Complications

Volumn 21, Issue 4, 2007, Pages 242-245

  McKnight, Amy Jayne ^a   Maxwell, A Peter ^a   Patterson, Chris C ^a   Brady, Hugh R ^b   Savage, David A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Dublin Molecular Medicine Centre   (Ireland)

Author keywords

Association; Nephropathy; SNP; Type 1 diabetes; VEGF

Indexed keywords

GENOMIC DNA; VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HETEROZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

ADOLESCENT; ALLELES; CASE-CONTROL STUDIES; CYTIDINE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; THYMIDINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34347251552     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.05.005     Document Type: Article

References (16)

1. Awata T., Inoue K., Kurihara S., Ohkubo T., Watanabe M., Inukai K., Inoue I., and Katayama S. A common polymorphism is the 5′ untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51 5 (2002) 1635-1639
2. Boreham C., Savage J.M., Primrose D., Cran G., and Strain J. Coronary risk factors in school-children. Archives of Disease in Childhood 68 (1993) 182-186
3. Brogan I.J., Khan N., Isaac K., Hutchinson J.A., Pravica V., and Hutchinson I.V. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Human Immunology 60 12 (1999) 1245-1249
4. Cha D.R., Kim N.H., Yoon J.W., Jo S.K., Cho W.Y., Kim H.K., and Won N.H. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney International. Supplement 77 (2000) S104-S112
5. De Vriese A.S., Tilton R.G., Elger M., Stephan C.C., Kriz W., and Lameire N.H. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. Journal of the American Society of Nephrology 12 5 (2001) 993-1000
6. Duh E., and Aiello L.P. Vascular endothelial growth factor and diabetes: The agonist versus antagonist paradox. Diabetes 48 (1999) 1899-1906
7. Hsieh Y.Y., Chang C.C., Tsai F.J., Yeh L.S., Lin C.C., and Peng C.T. T allele for VEGF gene-460 polymorphism at the 5′-untranslated region: Association with a higher susceptibility to endometriosis. Journal of Reproductive Medicine 49 6 (2004) 468-472
8. Ku K.T., Wan L., Peng H.C., Tsai M.H., Tsai C.H., and Tsai F.J. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer. Oral Oncology 41 5 (2005) 497-502
9. Ray D., Mishra M., Ralph S., Read I., Davies R., and Brenchley P. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 53 3 (2004) 861-864
10. Schrijvers B.F., Flyvbjerg A., and De Vriese A.S. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney International 65 6 (2004) 2003-2017
11. Stevens A., Soden J., Brenchley P.E., Ralph S., and Ray D.W. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Research 63 4 (2003) 812-816
12. Summers A. VEGF polymorphisms and diabetic nephropathy. [Abstract]. Nephrology Dialysis Tranplantation Suppl. 1 (2002) O80
13. Summers A. VEGF polymorphisms and diabetic nephropathy. [Abstract]. Journal of the American Society of Nephrology 13 (2002) 248A
14. Vincenti V., Cassano C., Rocchi M., and Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93 8 (1996) 1493-1495
15. Watson C.J., Webb N.J., Bottomley M.J., and Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine 12 8 (2000) 1232-1235
16. Yang B., Cross D.F., Ollerenshaw M., Millward B.A., and Demaine A.G. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. Journal of Diabetes and its Complications 17 1 (2003) 1-6